Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Mineralys (Nasdaq: MLYS) Launch-HTN Cuts BP 19.0 mmHg, Lands JAMA Research of Year

Summary by stocktitan.net
JAMA spotlights Mineralys’ Launch-HTN, the largest ASI hypertension trial with 1,083 patients, after lorundrostat cut BP up to 19.0 mmHg with
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

1 Articles

stocktitan.netstocktitan.net

Mineralys (Nasdaq: MLYS) Launch-HTN Cuts BP 19.0 mmHg, Lands JAMA Research of Year

JAMA spotlights Mineralys’ Launch-HTN, the largest ASI hypertension trial with 1,083 patients, after lorundrostat cut BP up to 19.0 mmHg with

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

stocktitan.net broke the news in on Friday, December 12, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

BP icon

BP

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal